NMN Clinical analysis

How to Verify NMN Purity: COAs, Lab Tests, β-NMN & Label Accuracy

Independent studies have found major label failures and isomer inconsistencies in commercial NMN. This guide shows how to read a COA, verify batch potency and distinguish meaningful testing from marketing.

Published
Last reviewed
Reading time
12 min
Sources cited
3
Laboratory quality-control scene illustrating lot-specific NMN identity, purity and documentation checks.
On this page

“99% pure NMN” is not enough information to judge an NMN supplement. The finished product should contain the labeled amount of the correct NMN isomer, in the tested batch, with credible contaminant and identity data. Independent research has shown why: some marketed NMN products have contained far less active ingredient than claimed, including products with essentially no detectable labeled NMN.

Why NMN quality deserves its own article

Many supplements can suffer from under-dosing or contamination, but NMN has unusually direct published evidence documenting label problems. An independent GeroScience analysis tested 18 commercial NMN supplements and found measured content ranging from essentially absent to near the declared amount, with some deviations reaching −100%. [1]

A 2026 analytical paper went one step further by separating α-NMN and β-NMN and applying the validated method to eight commercial products. The authors found substantial variation in isomer composition and undeclared or inaccurately labeled ingredients. [2]

What a strong NMN certificate of analysis should show

COA element Why it matters
Batch or lot number Links the report to the bottle you actually bought
Sample/product name Prevents a generic raw-material report being passed off as finished-product testing
Test date Shows the result is current enough to be relevant
Identity method Confirms the compound is NMN, ideally distinguishing β-NMN where claimed
Quantitative assay Measures how much NMN is actually present
Acceptance specification Shows the pass/fail range rather than only a result
Heavy metals Screens lead, arsenic, cadmium and mercury where appropriate
Microbiology Relevant for finished-product safety
Residual solvents / contaminants Important when manufacturing processes warrant testing
Laboratory identity Allows readers to assess whether the report is internal or independent

Purity percentage vs label-claim accuracy

A raw material can be 99.9% pure and the finished capsule can still be underdosed. “Purity” asks what fraction of the tested material is the target substance. “Potency” or assay asks how much target substance is actually in the finished product.

A good product therefore needs both identity and quantitative confirmation. A marketing badge saying “99.8% purity” without lot-matched finished-product data does not tell you whether a 500 mg capsule contains 500 mg.

β-NMN vs α-NMN

Most clinical supplementation research is framed around β-NMN. Isomer identity therefore matters when a brand claims that its product matches the clinical literature.

The 2026 Chng paper is important because its pentabromophenyl LC-MS/MS method could resolve α- and β-NMN under aqueous conditions rather than reporting an undifferentiated total. [3]

Consumers do not need to become analytical chemists. They do need to recognize that “NMN detected” and “correct β-NMN identity and amount verified” are different levels of evidence.

What does third-party tested mean?

It should mean an outside laboratory performed specified analyses. It does not automatically mean:

  • every batch was tested;
  • the finished product rather than only the raw powder was tested;
  • the lab tested the actual labeled dose;
  • the report distinguishes NMN isomers;
  • the product was tested for every relevant contaminant;
  • the brand has published the report.

Ask what was tested, on which lot, by which method, and whether you can see the report.

The Biohack Blueprint NMN testing-evidence ladder

To keep product reviews consistent, Biohack Blueprint uses a hierarchy rather than treating every “lab tested” badge as equivalent.

Level Evidence What it actually tells you
Level 4 — strongest Current, lot-matched finished-product report with numeric identity/potency and relevant contaminants The exact batch being sold was analytically checked after manufacturing
Level 3 Finished-product report with numeric potency, but current-lot matching is unclear That formula has been measured, but not necessarily your bottle
Level 2 Raw-material supplier COA or branded-ingredient specification The incoming ingredient met a specification before final manufacturing
Level 1 “Third-party tested,” GMP or ISO-lab claim without a public product-specific result A quality process is claimed, but the buyer cannot independently verify the measured serving
Level 0 No meaningful analytical documentation The label is doing almost all the evidentiary work

This hierarchy is deliberately strict. A Level 2 branded raw-material certificate can coexist with an excellent finished product; it simply answers a different question from a Level 4 finished-batch assay.

Four COA mismatches that should stop a buyer from overinterpreting a report

  • Wrong stage: the report tests bulk raw NMN, while the label claim is for finished capsules or powder after manufacturing.
  • Wrong SKU: a brand links testing for a 500 mg product while you are buying the 1,000 mg or liposomal formula.
  • Wrong lot: the document is real but belongs to a historical batch rather than the one being shipped.
  • Wrong analyte: the report proves heavy-metal compliance but never measures NMN identity or potency.

A fifth problem is subtler: a report may measure “total NMN” without resolving whether the material matches the β-NMN form emphasized in the clinical literature.

What a numerical potency result lets you calculate

If a laboratory reports a finished capsule at 513.2 mg against a 500 mg label, you can calculate label accuracy directly: measured amount ÷ label amount × 100. A vague “PASS” does not give the reader that information.

For powders, check whether the assay is reported as percentage by weight, mg/g or mg per defined scoop. Those units are convertible only if the sample mass and serving definition are clear.

Clinical evidence and analytical quality are two separate axes

A pristine COA does not prove a health benefit. It proves that the tested sample better matches what the label says. Conversely, a human RCT on a branded β-NMN ingredient does not prove that an unrelated retail bottle contains the same dose or even the correct amount of NMN.

Our product reviews therefore ask two independent questions:

  1. Did the exact bottle pass a strong analytical verification standard?
  2. How directly can human research be transferred to this ingredient, dose and formulation?

The strongest product would perform well on both axes. This is the framework used in our 2026 NMN comparison.

How to verify NMN quality

Red flags in NMN COAs

  • A report with no lot number or a lot number that does not match the bottle.
  • A report years older than the purchased batch.
  • A raw-material supplier certificate presented as finished-product testing.
  • Only heavy-metal testing with no NMN identity or potency assay.
  • Only a purity percentage with no mg-per-serving confirmation.
  • A cropped screenshot with laboratory and method information removed.
  • A brand that says 'third-party tested' but refuses to show documentation.
  • A report for one flagship product used to imply every SKU is tested identically.

Does FDA or EFSA testing guarantee product quality?

No. Dietary-supplement regulation does not mean FDA laboratory-tests each bottle before sale. An NDI notification is not batch certification. Likewise, EFSA's 2026 scientific opinion evaluated a specific β-NMN material and proposed use under a defined dossier; it does not authenticate every commercial product using the letters “NMN.” [4]

Does branded NMN guarantee quality?

A branded raw material can improve traceability and may have its own specifications or regulatory dossier, but the finished supplement still needs appropriate manufacturing and testing. The capsule can differ from the bulk ingredient through dose error, excipients, storage, degradation or supply-chain substitution.

How much potency deviation is acceptable?

There is no single universal percentage we can apply to every NMN product without reference to the product specification and applicable regulatory framework. The relevant point is that enormous deviations—especially products containing little or none of the declared active ingredient—are not small manufacturing noise.

How to verify an NMN product before buying

  • Find the exact product and serving size.
  • Look for a batch-specific COA, not a generic quality page.
  • Match the lot number.
  • Confirm NMN identity and quantitative assay.
  • Prefer β-NMN identity data when the label claims β-NMN.
  • Check contaminants appropriate to the dosage form.
  • Check the manufacturing and laboratory dates.
  • See whether the manufacturer names the testing laboratory and method.
  • Compare the COA dose with the Supplement Facts panel.

The three quality questions most NMN labels blur together

Identity asks whether the material is actually the claimed molecule. Purity asks what proportion of the tested material is the target compound rather than impurities. Potency asks how much target compound is present in the finished serving. A product can perform well on one and poorly on another.

For example, raw powder could be 99.8% pure β-NMN while a manufacturing error leaves the finished capsules with only 350 mg instead of a labeled 500 mg. A raw-material purity certificate would not detect the underfill.

What independent testing has found

What the independent label-accuracy study found

Sandalova and colleagues analytically tested marketed NMN products rather than relying on brand documentation. The measured amount of active ingredient varied widely relative to the label claim, with some products showing essentially no detectable labeled NMN. [5]

The practical implication is significant: if a trial used 300 mg/day of verified NMN, a retail product labeled “300 mg” cannot be assumed to reproduce that exposure without credible assay data.

Why β-NMN versus α-NMN matters

NMN exists as stereochemical/isomeric forms. The mainstream supplement and clinical literature centers on β-NMN. A generic assay that detects total NMN but does not resolve isomers can miss whether the material matches the form described on the label.

The 2026 Chng paper developed a fully aqueous LC-MS/MS method capable of separating α-NMN and β-NMN within minutes, then applied it to eight commercial supplements. The products showed substantial variation in isomer composition, including undeclared or inaccurate ingredients. [6]

How to read an NMN COA

Raw-material COA versus finished-product COA

Document What it can show What it cannot prove by itself
Raw-material supplier COA Identity/purity of incoming NMN powder Correct amount in the final capsule or scoop
In-house finished-product test Batch potency if method is valid Independent verification
Third-party finished-product COA Independent batch identity/potency and selected contaminants Every future batch unless each lot is tested
Marketing '99% pure' badge A claim Method, lot, actual serving potency or contaminant profile

How to read the assay line

A useful potency report should state the measured result and the acceptable specification. If a 500 mg serving is expected to contain within a defined manufacturing range, the report should make that relationship visible rather than merely reporting “pass.”

Also check whether the assay is performed on the finished dosage form. Testing one gram of supplier powder is not the same as testing a capsule after blending, encapsulation and storage.

Heavy metals, microbes and solvents

NMN identity is only one dimension of quality. Depending on the manufacturing process and dosage form, a finished-product panel may also include lead, arsenic, cadmium, mercury, microbial counts, pathogens and residual solvents.

A product can contain the correct amount of NMN and still fail on a contaminant specification. Conversely, a clean heavy-metal report tells you nothing about whether NMN is present at the labeled dose.

What does “GMP manufactured” tell you?

Good manufacturing practice addresses systems, documentation and process control. It is valuable, but it does not substitute for seeing the batch's analytical result. GMP status and product assay answer different questions.

What ISO/IEC 17025 laboratory accreditation means

ISO/IEC 17025 accreditation can indicate that a laboratory has demonstrated competence for specified testing scopes. It does not automatically validate every analysis the lab performs. Ideally, the relevant NMN identity or assay method should fall within an appropriate validated or accredited testing capability.

How a buyer can audit a COA in five minutes

  • Match the lot number on the bottle to the report.
  • Check the sample description: raw material or finished product?
  • Find the identity test and the quantitative NMN assay.
  • Check whether β-NMN is specifically verified where claimed.
  • Look at the measured result, units and acceptance range.
  • Confirm the report date and laboratory identity.
  • Check relevant contaminant tests rather than assuming one panel covers everything.
  • Be suspicious of a cropped image that hides sample, lot, method or lab details.

How Biohack Blueprint evaluates NMN purity

Why Amazon reviews cannot establish purity

A consumer cannot reliably detect a 20%, 50% or 100% potency shortfall by taste or perceived energy. Subjective response varies too much, and NMN itself does not have a unique sensory signature that validates identity.

Stability is part of purity over time

The COA may represent the product on the day it was tested. Shelf-life quality requires packaging, moisture control and stability data showing that potency remains within specification through expiration. This is especially important for powders or liquids exposed repeatedly to air and humidity.

How we will use purity in Biohack Blueprint reviews

Our product pages separate ingredient evidence from finished-product verification. A brand receives credit for transparent lot-specific testing, but a clinical trial on a branded raw material does not automatically validate every formula that uses it. That same standard will be applied in the best NMN supplement guide.

Related NMN guides

Bottom line

For NMN, the first buying question should not be “liposomal or capsule?” It should be “does this bottle contain the correct amount of the correct ingredient?” Published independent testing makes that a scientific concern, not consumer paranoia.

We apply this framework in our best NMN supplement guide and every brand review.

Frequently asked questions

What purity should NMN be?

High chemical purity is desirable, but there is no single percentage that replaces identity and potency testing. A product advertised as 99% pure can still be underdosed if the finished capsule does not contain the labeled amount.

How can I tell if an NMN supplement is real?

Look for lot-matched testing that confirms β-NMN identity and quantitative potency in the finished product. A current COA should also identify the laboratory, test method, sample and batch.

What should an NMN COA include?

At minimum, the exact product or sample name, lot number, test date, identity method, quantitative assay, acceptance specification and laboratory. Finished-product contaminant testing such as heavy metals and microbiology may also be relevant.

Does third-party tested mean every batch is tested?

Not necessarily. The phrase only says an outside laboratory performed some testing. Ask whether every lot is tested, whether the finished product or only the raw material was analyzed, and which tests were performed.

Is beta-NMN the form used in human studies?

Most clinical NMN supplementation literature is framed around β-NMN. Therefore a product claiming to match the research should verify the correct isomer rather than reporting undifferentiated total NMN alone.

Can I test NMN at home?

Home color, taste, solubility or appearance tests cannot replace validated analytical chemistry. Reliable identity and potency require methods such as chromatographic and mass-spectrometric testing.

Does a branded ingredient like Uthever guarantee the final product?

A branded raw material can improve traceability and may have its own specifications or clinical data, but the final capsule still depends on manufacturing accuracy, storage, excipients and supply-chain integrity. Finished-product verification remains valuable.

Can NMN degrade during storage?

Stability depends on moisture, heat, pH, packaging and formulation. Follow product-specific storage instructions and prefer products with stability and potency data that cover the labeled shelf life.

What does lot-matched NMN testing mean?

Lot-matched testing means the batch or lot number on the laboratory report corresponds to the specific production lot being sold. It is stronger than a generic or historical COA because a buyer can connect the test result to the actual bottle or container.

Is a raw-material NMN COA enough?

No. A raw-material COA can verify the incoming NMN powder, but it cannot prove that the finished capsule, scoop or multi-ingredient formula contains the correct amount after blending, filling, packaging and storage. Finished-product testing answers that separate question.

Share this article

Send the research to someone who would find it useful.

Facebook X LinkedIn Reddit WhatsApp Email

Sources & article history

Sources (3)
  1. Sandalova E, et al. Testing the amount of nicotinamide mononucleotide and urolithin A as compared to the label claim GeroScience. 2024;Volume 46, pages 5075–5083.
  2. Chng Sze Hoei, et al. Aqueous LC-MS/MS quantification of α-/β-nicotinamide mononucleotide in dietary supplements using a pentabromophenyl column Analytica Chimica Acta. 2026;1386:345027.
  3. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al. Safety of beta-nicotinamide mononucleotide (β-NMN) pursuant the regulation (EU) 2015/2283 and the bioavailability of nicotinamide from this source in the context of Directive 2002/46/EC EFSA Journal. 2026;24(5):e10007.